Voyager Life Limited, a health and wellness group focused on cannabidiol (CBD) and hemp seed oil products, said it plans to list on the Access segment of the Aquis Stock Exchange in the second quarter of 2021.
The company said the plans follows a crowdfunding campaign launched in February through which it raised £874,000, as well as a private fundraising for a further £741,000. The private funding round included a £100,000 commitment from Greencare Capital Plc (LON:GRE), an Aquis-listed investment firm focused on medicinal cannabis.
Voyager said it believes there is a “significant opportunity” in the CBD market due to “forecast growth and ongoing regulatory changes”, adding that it has a growing range of CBD and hemp seed oil products including oils, gummies, bath products and skincare products.
“We believe this is a sector with significant growth potential and our focus has been on building our product range alongside a robust approach to assurance and compliance as strong foundations to build the brand and the business. The Voyager team has extensive industry experience and our oversubscribed crowdfunding along with the strong support in our more recent fundraising underlines the significant investor appetite for our approach”, Voyager chief executive Nick Tulloch said in a statement.
“At the time of our crowdfunding campaign in February 2021, we were clear with investors that our aspirations were to take Voyager onto the public markets when the time was right. The progress made by the business, coupled with strong investor backing, has enabled us to realise these plans far more rapidly than we originally envisaged. We believe that Aquis provides an ideal platform for Voyager to continue to build its profile and provide our investors with liquidity whilst maintaining the Company’s EIS-qualifying status”, he added.